Engineered adeno-associated virus vector yields high transduction of the brain vasculature

Researchers have developed an engineered adeno-associated virus (AAV) vector that yields high transduction of brain vascular pericytes and smooth muscle cells.

CD70 CAR-T by UTC Therapeutics for Burkitt Lymphoma: Likelihood of Approval

GlobalData tracks drug-specific phase transition and likelihood of approval scores, in addition to indication benchmarks based off 18 years of historical drug development data. Attributes

August 10, 2023

Novartis shares updated data for BTK inhibitor; Astellas resubmits BLA for cancer drug after CRL

Plus, news about Valar Labs, Pharming Group and Day One Pharmaceuticals: Novartis outlines one-year data for BTK inhibitor: The drug, called remibrutinib, Sign up to

June 1, 2024

New obesity drugs are seemingly everywhere. Black Americans feel left out

STAT teamed up with Word In Black, a network of 10 Black news publishers, to report over the past year on the impact of new

May 29, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.